絞り込み

16643

広告

スターを付ける スターを付ける     (21view , 0users)

Full Text Sources

Medical

Miscellaneous

The increase in drug frequency or dose is recommended for acromegaly patients with partial response to long-acting somatostatin receptor ligands (SRLs). However, the efficacy and safety data with lanreotide autogel (LAN-ATG) at high-dose (HD) or high-frequency (HF) are still scanty and anecdotal.
PMID: 28419317 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード